What is the appropriate management for a 14-year-old patient with microscopic hematuria (5-10 Red Blood Cells (RBC) per high power field (hpf)) in the urine, suggestive of a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Microscopic Hematuria (5-10 RBC/hpf) in a 14-Year-Old Patient

In a 14-year-old with 5-10 RBC/hpf and clinical suspicion of UTI (presence of white blood cells, bacteria, or urinary symptoms), treat the infection first with appropriate antibiotics and repeat urinalysis 6 weeks after treatment completion—if hematuria resolves, no further workup is needed. 1

Initial Diagnostic Approach

Confirm True Hematuria and Assess for Infection

  • Verify microscopic hematuria with properly collected clean-catch midstream urine specimen showing ≥3 RBCs/hpf (5-10 RBC/hpf meets this threshold) 2
  • Examine the complete urinalysis for white blood cells, bacteria, leukocyte esterase, and nitrites to identify UTI as the likely cause 1
  • Obtain urine culture before initiating antibiotics to confirm infection and guide antibiotic selection 1
  • Assess for proteinuria using dipstick (≥2+ suggests glomerular disease requiring different evaluation pathway) 2

Key Clinical Features to Elicit

  • Urinary symptoms: dysuria, frequency, urgency, suprapubic pain (suggest UTI) 1
  • Flank pain or costovertebral angle tenderness (suggest pyelonephritis or nephrolithiasis) 2
  • Recent pharyngitis or skin infection (suggest post-infectious glomerulonephritis) 2
  • Family history of kidney disease, hearing loss, or hematuria (suggest hereditary nephropathy like Alport syndrome or thin basement membrane disease) 2
  • Recent trauma (even minor trauma in children can cause hematuria due to anatomical vulnerability) 2

Management Algorithm Based on Clinical Presentation

If UTI is Present (Most Likely Scenario)

Treat the infection and reassess:

  • Initiate appropriate antibiotic therapy based on local resistance patterns—first-line options include trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, nitrofurantoin, or cephalexin 3, 4
  • Repeat urinalysis 6 weeks after completing antibiotics to document resolution of hematuria 1
  • If hematuria resolves with treatment, no additional evaluation is necessary 1
  • If hematuria persists after successful UTI treatment, proceed with complete evaluation as outlined below 1

If No UTI is Present (Isolated Microscopic Hematuria)

In children with isolated microscopic hematuria without proteinuria or dysmorphic RBCs, no imaging is indicated initially:

  • No imaging is recommended for asymptomatic microscopic hematuria without proteinuria in children, as clinically significant renal disease is unlikely 2
  • Clinical observation with repeat urinalysis on 2-3 consecutive specimens to confirm persistence 2
  • Screen family members' urine for benign familial hematuria or thin basement membrane nephropathy 2
  • Evaluate for hypercalciuria with spot urine calcium-to-creatinine ratio, as this is a common benign cause in children 2

Red Flags Requiring Immediate Further Evaluation

Proceed directly to imaging and nephrology referral if any of the following are present:

  • Proteinuria ≥2+ on dipstick (suggests glomerular disease) 2
  • Dysmorphic RBCs or red blood cell casts on microscopy (pathognomonic for glomerulonephritis) 2, 5
  • Tea-colored or cola-colored urine (suggests glomerular bleeding) 2, 5
  • Hypertension, edema, or elevated creatinine (suggests renal parenchymal disease) 2
  • Macroscopic (gross) hematuria (requires ultrasound to exclude tumors, stones, or structural abnormalities) 2

Pediatric-Specific Considerations

Why Children Are Different

  • Microscopic hematuria <50 RBC/hpf is common in children (1-36% prevalence) due to kidney anatomy and undiagnosed kidney diseases 2
  • The threshold for imaging in trauma is >50 RBC/hpf in children, unlike adults where lower thresholds apply 2
  • Isolated microscopic hematuria in children is usually benign and often resolves spontaneously 2
  • Glomerulonephritis (especially post-infectious and IgA nephropathy) is more common than malignancy in pediatric hematuria 2

Age-Appropriate Imaging When Indicated

  • Ultrasound is the preferred initial imaging modality in children to assess kidney size, echogenicity, structural abnormalities, and bladder lesions 2
  • CT is not appropriate for initial evaluation of isolated nonpainful, nontraumatic hematuria in children due to radiation exposure 2
  • Ultrasound should include bladder evaluation when distended with urine to assess for polyps, masses, or vascular lesions 2

Common Pitfalls to Avoid

  • Do not attribute hematuria to "normal variation" without proper evaluation—while <50 RBC/hpf may not require imaging in trauma, 5-10 RBC/hpf with UTI symptoms requires treatment and follow-up 2, 1
  • Do not perform extensive imaging workup before treating obvious UTI—treat infection first and reassess 1
  • Do not ignore persistent hematuria after UTI treatment—this requires complete urologic evaluation 1
  • Do not overlook proteinuria—even trace proteinuria with hematuria warrants nephrology evaluation 2
  • Do not dismiss family history—benign familial hematuria and thin basement membrane nephropathy are autosomal dominant and common causes of persistent microscopic hematuria in children 2

References

Guideline

Management of Urinary Tract Infections with Hematuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Uncomplicated Urinary Tract Infection in Ambulatory Primary Care Pediatrics: Are We Using Antibiotics Appropriately?

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2019

Guideline

Hematuria Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.